ExodusPoint Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-26,329
| Closed | -$294K | – | 1546 |
|
|
2023
Q3 | $294K | Buy |
+26,329
| New | +$294K | ﹤0.01% | 1378 |
|
|
2023
Q2 | – | Sell |
-20,147
| Closed | -$815K | – | 1851 |
|
|
2023
Q1 | $815K | Buy |
+20,147
| New | +$815K | 0.01% | 1114 |
|
|
2022
Q4 | – | Sell |
-12,804
| Closed | -$664K | – | 1695 |
|
|
2022
Q3 | $664K | Buy |
+12,804
| New | +$664K | 0.01% | 1237 |
|
|
2022
Q1 | – | Sell |
-5,568
| Closed | -$416K | – | 2244 |
|
|
2021
Q4 | $416K | Buy |
+5,568
| New | +$416K | ﹤0.01% | 1470 |
|
|
2020
Q4 | – | Sell |
-6,292
| Closed | -$288K | – | 1984 |
|
|
2020
Q3 | $288K | Buy |
+6,292
| New | +$288K | 0.01% | 1252 |
|